122 related articles for article (PubMed ID: 1708857)
1. [Multidisciplinary therapy using interferon and immunological evaluation for glioma patients: two-color analysis of T cell subsets].
Numa Y; Kawamoto K; Matsumura H
No Shinkei Geka; 1991 Feb; 19(2):121-8. PubMed ID: 1708857
[TBL] [Abstract][Full Text] [Related]
2. [Subset analysis of tumor infiltrating lymphocytes and peripheral blood lymphocytes in malignant glioma patients].
Matsuhisa T
No To Shinkei; 1995 May; 47(5):466-73. PubMed ID: 7786623
[TBL] [Abstract][Full Text] [Related]
3. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
Karavodin LM; Golub SH
Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
[TBL] [Abstract][Full Text] [Related]
4. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
[TBL] [Abstract][Full Text] [Related]
5. [Local immunotherapy with OK-432 for malignant gliomas--immunohistochemical analysis of chronological changes of tumor tissues].
Saito T; Tanaka R; Sekiguchi K; Yoshida S; Washiyama K; Yamada N; Takeda N
No To Shinkei; 1988 Jul; 40(7):609-15. PubMed ID: 3224036
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of the immunosuppressive mechanism in patients with malignant brain tumors].
Yoshida S
No To Shinkei; 1985 Dec; 37(12):1137-43. PubMed ID: 3879181
[TBL] [Abstract][Full Text] [Related]
7. Normal values of peripheral lymphocyte populations and T cell subsets at a fixed time of day: a flow cytometric analysis with monoclonal antibodies in 210 healthy adults.
Ohta Y; Fujiwara K; Nishi T; Oka H
Clin Exp Immunol; 1986 Apr; 64(1):146-9. PubMed ID: 2942319
[TBL] [Abstract][Full Text] [Related]
8. [Deficit of natural killer cells (NK cells) in the peripheral blood of patients with atopic dermatitis].
Reinhold U; Wehrmann W; Bauer R; Kreysel HW
Hautarzt; 1986 Aug; 37(8):438-43. PubMed ID: 2944856
[TBL] [Abstract][Full Text] [Related]
9. Relative sensitivity of human T cell subsets to deoxyadenosine toxicity.
Callard RE; Ewing TM; Fox RM
Clin Exp Immunol; 1984 Oct; 58(1):136-44. PubMed ID: 6236916
[TBL] [Abstract][Full Text] [Related]
10. [Subsets of peripheral blood lymphocytes and tumor infiltrating lymphocytes in cancer patients received chemotherapy].
Mitachi Y; Murakawa Y; Okuno M; Kambe M; Kanamaru R; Takahasi H; Wakui A
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):482-8. PubMed ID: 2138871
[TBL] [Abstract][Full Text] [Related]
11. [Immunophenotyping of lymphocyte subpopulations using monoclonal antibodies in an analytical flow cytometer: evaluation of the method and reference values].
Neumeier D; Pauls R; Wifling I; Fateh-Moghadam A; Knedel M
J Clin Chem Clin Biochem; 1985 Nov; 23(11):765-75. PubMed ID: 4086981
[TBL] [Abstract][Full Text] [Related]
12. Parameters of interferon action: II. Immunological effects of recombinant leukocyte interferon (IFN-alpha 2) in phase I-II trials.
Ernstoff MS; Fusi S; Kirkwood JM
J Biol Response Mod; 1983; 2(6):540-7. PubMed ID: 6607324
[TBL] [Abstract][Full Text] [Related]
13. [Long-term immunological study on postoperative adjuvant treatment with interferon-gamma in patients with renal cell carcinoma who underwent nephrectomy].
Miura H; Arai H; Matsuoka A; Yazawa K; Satoh E; Nishimura K; Honda M; Fujioka H
Hinyokika Kiyo; 1999 Feb; 45(2):79-83. PubMed ID: 10212778
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of tumor-infiltrating lymphocyte in primary malignant lymphoma of the central nervous system using double immunofluorescence staining method].
Kunishio K; Matsuhisa T; Maeshiro T; Tsuno K; Shigematsu H; Mishima N; Matsumoto K; Furuta T; Ohmoto T; Nishimoto A
No To Shinkei; 1992 Feb; 44(2):125-30. PubMed ID: 1533133
[TBL] [Abstract][Full Text] [Related]
15. [Combination therapy with IFN-beta, ACNU and radiation (IAR) in malignant brain tumors].
Yoshida J; Wakabayashi T; Kato K; Enomoto H; Kito A; Kageyama N
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):520-4. PubMed ID: 3456740
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study on the effect of intratumoral administration of OK-432 on breast cancer--anti-tumor immune response at the site of local injection].
Hosokawa T
Nihon Geka Gakkai Zasshi; 1991 May; 92(5):577-86. PubMed ID: 1831533
[TBL] [Abstract][Full Text] [Related]
17. T lymphocyte subsets in the peripheral blood in patients with primary biliary cirrhosis.
Shin T; Mizoguchi Y; Kawada N; Kobayashi K
Arerugi; 1989 Jun; 38(6):501-7. PubMed ID: 2589983
[TBL] [Abstract][Full Text] [Related]
18. Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.
Charreire J; Karsenty G; Bouchard P; Schaison G
Clin Exp Immunol; 1984 Sep; 57(3):633-8. PubMed ID: 6147216
[TBL] [Abstract][Full Text] [Related]
19. Two-color analysis of lymphocyte subpopulations in patients with nephrotic syndrome due to membranous nephropathy.
Ozaki T; Tomino Y; Nakayama S; Koide H
Clin Nephrol; 1992 Aug; 38(2):75-80. PubMed ID: 1516283
[TBL] [Abstract][Full Text] [Related]
20. [Improvement of host-immunity by adjuvant therapy with juzen-taiho-to for patients with brain tumors].
Miyagami M; Katayama Y
No Shinkei Geka; 2003 Apr; 31(4):401-9. PubMed ID: 12704821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
